ST. LOUIS, May 24, 2021 /PRNewswire/ -- Centene
Corporation (NYSE: CNC) today announced that Suzy DePrizio has been appointed as Senior Vice
President, Chief Marketing Officer, effective today. Ms. DePrizio
will play a critical role leading the marketing strategy, brand
position and advertising for the company.
Prior to joining Centene, Ms. DePrizio led Digital and eCommerce
transformation for the Johnson & Johnson U.S. Consumer Health
business, where she was responsible for accelerating growth and
driving market leadership in online sales. Previously, she was
Chief Marketing Officer and Head of Customer Strategy for Johnson
& Johnson Consumer Health Canada.
"Suzy brings a unique skillset to our leadership team with 16
years of marketing leadership experience in the consumer health
industry with Johnson & Johnson," said Brent Layton, Executive Vice President and
President of U.S. Health Plans, Products, and International.
"Suzy's expertise and leadership will be critical in helping
Centene continue to build its brands and drive growth among its
diverse product portfolio."
Prior to joining Johnson & Johnson, Suzy served as an
officer in the U.S. Navy for over nine years, with worldwide
assignments spanning four continents. Suzy holds a Bachelor of
Arts, Government, from Harvard
University and a Master of Business Administration from
Duke University, The Fuqua School of
Business.
About Centene Corporation
Centene Corporation, a Fortune 50 company, is a leading
multi-national healthcare enterprise that is committed to helping
people live healthier lives. The Company takes a local approach –
with local brands and local teams – to provide fully integrated,
high-quality, and cost-effective services to government-sponsored
and commercial healthcare programs, focusing on under-insured and
uninsured individuals. Centene offers affordable and
high-quality products to nearly 1 in 15 individuals across the
nation, including Medicaid and Medicare members (including Medicare
Prescription Drug Plans) as well as individuals and families served
by the Health Insurance Marketplace, the TRICARE program, and
individuals in correctional facilities. The Company also serves
several international markets, and contracts with other healthcare
and commercial organizations to provide a variety of specialty
services focused on treating the whole
person. Centene focuses on long-term growth and the
development of its people, systems and capabilities so that it can
better serve its members, providers, local communities, and
government partners.
Centene uses its investor relations website to publish important
information about the Company, including information that may be
deemed material to investors. Financial and other information about
Centene is routinely posted and is accessible on Centene's investor
relations website, http://www.centene.com/investors.
Forward-Looking Statements
All statements, other than statements of current or historical
fact, contained in this press release are forward-looking
statements. Without limiting the foregoing, forward-looking
statements often use words such as "believe," "anticipate," "plan,"
"expect," "estimate," "intend," "seek," "target," "goal," "may,"
"will," "would," "could," "should," "can," "continue" and other
similar words or expressions (and the negative thereof). Centene
(the Company, our, or we) intends such forward-looking statements
to be covered by the safe-harbor provisions for forward-looking
statements contained in the Private Securities Litigation Reform
Act of 1995, and we are including this statement for purposes of
complying with these safe-harbor provisions. In particular, these
statements include, without limitation, statements about our future
operating or financial performance, market opportunity, growth
strategy, competition, expected activities in completed and future
acquisitions, including statements about the impact of our proposed
acquisition of Magellan Health (the Magellan Acquisition), our
recently completed acquisition of WellCare Health Plans, Inc.
(WellCare and such acquisition, the WellCare Acquisition), other
recent and future acquisitions, investments and the adequacy of our
available cash resources. These forward-looking statements reflect
our current views with respect to future events and are based on
numerous assumptions and assessments made by us in light of our
experience and perception of historical trends, current conditions,
business strategies, operating environments, future developments
and other factors we believe appropriate. By their nature,
forward-looking statements involve known and unknown risks and
uncertainties and are subject to change because they relate to
events and depend on circumstances that will occur in the future,
including economic, regulatory, competitive and other factors that
may cause our or our industry's actual results, levels of activity,
performance or achievements to be materially different from any
future results, levels of activity, performance or achievements
expressed or implied by these forward-looking
statements. These statements are not guarantees of future
performance and are subject to risks, uncertainties and
assumptions. All forward-looking statements included in this press
release are based on information available to us on the date
hereof. Except as may be otherwise required by law, we undertake no
obligation to update or revise the forward-looking statements
included in this press release, whether as a result of new
information, future events or otherwise, after the date
hereof. You should not place undue reliance on any forward-looking
statements, as actual results may differ materially from
projections, estimates, or other forward-looking statements due to
a variety of important factors, variables and events including, but
not limited to: the impact of COVID-19 on global markets, economic
conditions, the healthcare industry and our results of operations
and the response by governments and other third parties to
COVID-19; the risk that regulatory or other approvals
required for the Magellan Acquisition may be delayed or not
obtained or are subject to unanticipated conditions that could
require the exertion of management's time and our resources or
otherwise have an adverse effect on us; the possibility
that certain conditions to the consummation of the Magellan
Acquisition will not be satisfied or completed on a timely basis
and accordingly the Magellan Acquisition may not be consummated on
a timely basis or at all; uncertainty as to the expected financial
performance of the combined company following completion of the
Magellan Acquisition; the possibility that the expected
synergies and value creation from the Magellan Acquisition or the
WellCare Acquisition will not be realized, or will not be realized
within the respective expected time periods; the risk that
unexpected costs will be incurred in connection with the completion
and/or integration of the Magellan Acquisition or that the
integration of Magellan Health will be more difficult or time
consuming than expected; the risk that potential litigation in
connection with the Magellan Acquisition may affect the timing or
occurrence of the Magellan Acquisition or result in significant
costs of defense, indemnification and liability; a downgrade of the
credit rating of our indebtedness, which could give rise to an
obligation to redeem existing indebtedness; the
inability to retain key personnel; disruption from the
announcement, pendency, completion and/or integration of the
Magellan Acquisition or from the integration of the WellCare
Acquisition, or similar risks from other acquisitions we may
announce or complete from time to time, including potential adverse
reactions or changes to business relationships with customers,
employees, suppliers or regulators, making it more difficult to
maintain business and operational relationships; our ability to
accurately predict and effectively manage health benefits and other
operating expenses and reserves, including fluctuations in medical
utilization rates due to the impact of
COVID-19; competition; membership and revenue declines
or unexpected trends; changes in healthcare practices, new
technologies and advances in medicine; increased healthcare costs;
changes in economic, political or market conditions; changes in
federal or state laws or regulations, including changes with
respect to income tax reform or government healthcare programs as
well as changes with respect to the Patient Protection and
Affordable Care Act and the Health Care and Education Affordability
Reconciliation Act (collectively referred to as the ACA) and any
regulations enacted thereunder that may result from changing
political conditions, the new administration or judicial actions,
including the ultimate outcome in "Texas v. United States of America" regarding the
constitutionality of the ACA; rate cuts or other payment reductions
or delays by governmental payors and other risks and uncertainties
affecting our government businesses; our ability to adequately
price products; tax matters; disasters or major epidemics; changes
in expected contract start dates; provider, state, federal, foreign
and other contract changes and timing of regulatory approval of
contracts; the expiration, suspension, or termination of our
contracts with federal or state governments (including, but not
limited to, Medicaid, Medicare, TRICARE or other customers); the
difficulty of predicting the timing or outcome of pending or future
legal and regulatory proceedings or government investigations;
challenges to our contract awards; cyber-attacks or other privacy
or data security incidents; the possibility that the expected
synergies and value creation from acquired businesses, including
businesses we may acquire in the future, will not be realized, or
will not be realized within the expected time period; the exertion
of management's time and our resources, and other expenses incurred
and business changes required in connection with complying with the
undertakings in connection with any regulatory, governmental or
third party consents or approvals for acquisitions, including the
Magellan acquisition; disruption caused by significant
completed and pending acquisitions making it more difficult to
maintain business and operational relationships; the risk that
unexpected costs will be incurred in connection with the completion
and/or integration of acquisition transactions; changes in expected
closing dates, estimated purchase price and accretion for
acquisitions; the risk that acquired businesses will not be
integrated successfully; restrictions and limitations in connection
with our indebtedness; our ability to maintain or achieve
improvement in the Centers for Medicare and Medicaid Services (CMS)
Star ratings and maintain or achieve improvement in other quality
scores in each case that can impact revenue and future growth;
availability of debt and equity financing, on terms that are
favorable to us; inflation; foreign currency fluctuations and risks
and uncertainties discussed in the reports that Centene has filed
with the Securities and Exchange Commission. This list of important
factors is not intended to be exhaustive. We discuss certain of
these matters more fully, as well as certain other factors that may
affect our business operations, financial condition and results of
operations, in our filings with the Securities and Exchange
Commission (SEC), including our annual report on Form 10-K,
quarterly reports on Form 10-Q and current reports on Form 8-K. Due
to these important factors and risks, we cannot give assurances
with respect to our future performance, including without
limitation our ability to maintain adequate premium levels or our
ability to control our future medical and selling, general and
administrative costs.
View original
content:http://www.prnewswire.com/news-releases/centene-appoints-suzy-deprizio-as-chief-marketing-officer-301297434.html
SOURCE Centene Corporation